Posters

Please note the programme is subject to change.


Monday, May 21, 2018

16.30-18.30 Poster Session
Nautica Hall & Nautica Foyer
   
P 001 Childhood thrombosis in  patients with acute leukemia
Aytac, Selin (Turkey)

P 002 Minimal Residual Disease in Philadelphia-positive Acute Lymphoblastic Leukemia by PCR-based quantification of BCR-ABL1 and Antigen Receptors in pediatric patients treated with ALLIC protocols
Alonso, Cristina N. (Argentina)

P 003 Very low incidende of ETV6/RUNX1 fusion in children from Guatemala treated according to modified ALL Intercontinental Berlin- Frankfurt-Munster (IC-BFM) 2002 protocol
Antillon, Federico (Guatemala)

P 004 HLA associations of asparaginase allergy
Daniel, Erdelyi (Hungary)

P 005 Comprehensive immunophenotyping panel in Japan enables to detect rare subtypes in childhood leukemia
Deguchi, Takao (Japan)

P 006 Novel NIPBL germline pathogenic variant in a CdLS patient with childhood ALL: cohesin involvement in ALL
Fazio, Grazia (Italy)

P 007 Pre-clinical studies on PAX5 fusion gene targeting in pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
Fazio, Grazia (Italy)

P 008 DAY+8 Response by Flow Cytometry: Prognostic Impact in AIEOP-BFM 2000 Study
Gaipa, Giuseppe (Italy)

P 009 Clinical-grade transduction of allogeneic Cytokine Induced Killer (CIK) cells with CD19 Chimeric Antigen Receptor (CAR) using Sleeping Beauty transposon
Gaipa, Giuseppe (Italy)

P 010 SRC/ABL inhibition disrupts coordinated CRLF2-driven signaling  to induce cell death in CRLF2-rearranged Acute Lymphoblastic Leukemia
Gaipa, Giuseppe (Italy)

P 011 Children with acute lymphoblastic leukaemia and abnormalities at chromosome 9: clinical and laboratory characteristics and outcome
Kapetaniou, Konstantina (Greece)

P 012 Long – term Results of the Brazilian Childhood Cooperative Group for Treatment of Acute Lymphoblastic Leukemia in Children (GBTLI ) : Studies - 80, - 82, - 85, - 93, - 99 and - 2009
Lee, Maria Lucia (Brazil)

P 013 Different stroma cell signaling after contact to acute lymphoblastic leukemia B-cells derived from adult and pediatric patients
Lutzny-Geier, Gloria (Germany)

P 014 Incidence of clinical allergy to asparaginase in pediatric patients with acute lymphoblastic leukemia. Comparison of native versus pegylated E.coli asparaginase in the same clinical protocol
Mesegue, Montserrat (Spain)

P 015 Genomic landscape of pediatric pre-B ALL
Oksa, Laura (Finland)

P 016 EXTRAMEDULLARY LATE RELAPSES INATYPICAL SITES OF ACUTE LYMPHOBLASTIC LEUKEMIA: A RETROSPECTIVE STUDY OF THE ITALIAN ASSOCIATION OF PEDIATRIC HEMATOLOGY AND ONCOLOGY (AIEOP)
Giagnuolo, Giovanna (Italy)

P 017 Molecular profiling of ETV6-RUNX1-positive pediatric leukemia using scRNA-seq
Teppo, Susanna (Finland)

P 018 Normalization of Acute Lymphoblastic Leukemia gene expression data using the cellular volume
Vasconcelos, Victor (Brazil)

P 019 Imatinib addition to intensive chemotherapy for the treatment of children and adolescents with Philadelphia-chromosome positive acute lymphoblastic leukemia: a multicenter study from the GATLA group
Zanella, María José Lorena (Argentina)

P 020 Refractory Cytopenia of Childhood (RCC)/ Myelodysplastic Syndromes (MDS) in children, adolescents and young adults: experience in a cohort of GATLA group patients
Zanella, María José Lorena (Argentina)

P 021 CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES IN PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN ELEVEN HEALTH CENTERS OF ARGENTINA FROM GATLA GROUP
Zanella, María José Lorena (Argentina)

P 022 High expression of SOX11 is associated with good prognosis in pediatric precursor B-ALL
Grönroos, Toni (Finland)

P 023 INCIDENCE OF TRAUMATIC LUMBAR PUNCTURE IN PEDIATRIC HEMATO-ONCOLOGIC PATIENTS
Lehtinen, Rami (Finland)

P 024 Systematic review of microRNAs involved in acute lymphoblastic leukemia
Lopez-Lopez, Elixabet (Spain)

P 025 Abstract was withdrawn

P 026 Clinical characteristics and analysis of outcome of children with Ph-positive acute lymphoblastic leukemia in Poland between 2005 and 2017.  (Polish Pediatric Leukemia and Lymphoma Study Group Report)
Drabko, Katarzyna (Poland)

P 027 Involvement of miRNA polymorphisms in hepatotoxicity development in childhood acute lymphoblastic leukemia
Garcia-Orad, Africa (Spain)

P 028 Increased mRNA expression of IGF1R and INSR are associated with lower overall survival in B-cell precursor acute lymphoblastic leukemia
Artico, Leonardo Luís (Brazil)

P 029 CD44 Expression in T-cell Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia and its Association with Alterations in Oncogenic Pathways
Codeço-Marques, Luísa (Brazil)

P 030 Transcriptome analysis of childhood Acute Lymphoblastic Leukemia samples revealed that disease outcome might be associated with the dysregulation of several non-coding RNAs
Cotignola, Javier (Argentina)

P 031 The use of bovine colostrum against chemotherapy-induced gastrointestinal toxicity in children with acute lymphoblastic leukemia: a double-blind placebo-controlled randomized trial
De Pietri, Silvia (Denmark)

P 032 UNUSUAL CO-EXISTENCE OF NOTCH1 MUTATION AND MLL REARRANGEMENT IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE REPORT
Esperanza Cebollada, Elena (Spain)

P 033 Dasatinib-combined less intensive chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia in Down syndrome
Hasegawa, Daisuke (Japan)

P 034 A cost-effectiveness analysis of Erwinia asparaginase therapy in children with acute lymphoblastic leukemia
Kloos, Robin (Netherlands)

P 035 Genome-wide analysis of the regulatory landscape in different pre-B-ALL subtypes
Lahnalampi, Mari (Finland)

P 036 The interplay between IKZF1 and COBL deletions in acute lymphoblastic leukemia
Lopes, Bruno (Germany)

P 037 DCAL goes NGS: Unveiling the complexity of MLL rearrangements using targeted-DNA sequencing
Lopes, Bruno (Germany)

P 038 Detection of minimal residual disease in ALL by artificial intelligence of cell images
Masic, Dino (United Kingdom)

P 039 Next Generation Sequencing of IgH standardization for Minimal Residual Disease quantification in childhood Acute Lymphoblastic Leukemia
Navarro Nilo Giusti, Guilherme (Brazil)

P 040 Characterisation of the Bone Marrow Stromal Compartment in Paediatric Acute Lymphoblastic Leukaemia
Revesz, Tom (Australia)

P 041 Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma
Semsei, Agnes (Hungary)

P 042 Identification and characterization of a novel NCOR1-LYN fusion gene in pediatric B-cell precursor acute lymphoblastic leukemia with IKZF1 deletion
Tomii, Toshihiro (Japan)

P 043 Identification of ruxolitinib resistance mutations in Pro-B cells driven by a high-risk B-ALL JAK2-fusion
White, Deborah L (Australia)

P 044 ANALYSIS AND CLINICAL SIGNIFICANCE OF TISSUE FACTOR POSITIVE, PLATELET AND ENDOTHELIAL MICROPARTICULE LEVELS DURING INDUCTION THERAPY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
Tüfekçi, Özlem (Turkey)

P 045 THE INVESTIGATION OF RELATIONSHIP BETWEEN FOK1 AND COL1A1 GENE POLYMORPHISMS AND DEVELOPMENT OF TREATMENT-RELATED BONE COMPLICATIONS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
Tüfekçi, Özlem (Turkey)

P 046 Amsacrine, etoposide and methylprednisolone as part of the therapy intensification in children with acute lymphoblastic leukemia : a retrospective analysis in the trial CoALL 08-09
Wos, Katharina (Germany)

P 047 Acute Nervous System Complications During Treatment of Acute Lymphoblastic Leukemia in Children
Yılmaz Karapınar, Deniz (Turkey)

P 048 Frequency of IGH deletions in Childhood Acute Lymphoblastic Leukemia
Yılmaz Karapınar, Deniz (Turkey)

P 049 Prognostic impact of hypodiploid cell lines evaluated through DNA index in pediatric precursor B-ALL for risk stratification
Bernasconi, Andrea (Argentina)

P 050 PAX5-RBPMS - a novel amplified PAX5 fusion gene in a case of a BCP-ALL
Haslinger, Sabrina (Austria)

P 051 Polymorphisms in genes included in folate metabolism and susceptibility to acute lymphoblastic leukemia in children
Biljana, Choneska Jovanova (Macedonia)

P 052 Clinical impact of Minimal Residual Disease in Acute Lymphoblastic Leukemia by Flow Cytometry on days 33 and 78 in ALLIC-2009 patients from SAHOP
Felice, Maria S. (Argentina)

P 053 Characterization of BRCA1 and BRCA2 expression and mutational status of NBS1, FANCD2 and PALB2 in biological subgroups of childhood ALL
Lo Nigro, Luca (Italy)

P 054 The new quantitative next generation sequencing based approach for minimal residual disease monitoring in childhood acute lymphoblastic leukemia
Mamedov, Ilgar (Russia)

P 055 Recurrent fusions genes in childhood B-Other Acute Lymphoblastic Leukemia
Migita, Natacha Azussa (Brazil)

P 056 Purinethol induced Steven Johnson like rash during maintenance therapy of acute lymphoblastic leukemia
Rosenfeld, Hila (Israel)

P 057 Early T precursor (ETP) Acute Lymphoblastic Leukemia: SAHOP experience
Rossi, Jorge G. (Argentina)

P 058 CRLF2 ANTIGEN EXPRESSION PATTERNS REFLECTING GENOTYPE OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA SUBTYPE
Terra-Granado, Eugênia (Brazil)

P 059 Improved definition of bone marrow sample representativeness during antileukemic therapy
Vakrmanová, Barbora (Czech Republic)

P 060 A multimodal high-throughput genomic strategy to refine risk stratification and widen access to modern therapy for ALL in India: the ICiCLe initiative
Parihar, Mayur (India)

P 061 Molecular Characterization of Smac Mimetic-sensitive and -resistant B-Cell Precursor Acute Lymphoblastic Leukemia
Zinngrebe, Julia (Germany)

P 062 Minimal Residual Disease in T-ALL treated with the ALLIC-09-BFM protocol in SAHOP (Sociedad Argentina Hemato-Oncología Pediátrica): Antigen modulation and blast clearance evaluation
Sajaroff, Elisa (Argentina)

P 063 PHENOTYPIC ALTERATIONS OF GRANULOCYTES IN PEDIATRIC B-CELL PRECURSOR ACUTE LIMPHOBLASTIC LEUKEMIA PATIENTS IN A SINGLE INSTITUTION
Pont, Sandra (Spain)

P 064 RARE SITES OF EXTRAMEDULLARY ACUTE LYMPHOBLASTIC LEUKAEMIA IN CHILDREN OLDER THAN ONE YEAR-OLD
Baka, Margarita (Greece)

P 065 Children with acute myeloid  leukemia and MLL gene rearrangement:  Characteristics in diagnosis,  therapy response and final outcome
Baka, Margarita (Greece)

P 066 ACUTE MYELOID LEUKEMIA IN A 13 YEAR-OLD MALE PATIENT AFTER KIDNEY  TRANSPLANTATION WITH t(6;9)(p22;q34).  A CASE REPORT
Baka, Margarita (Greece)

P 067 LIGANDS FOR INHIBITORY AND ACTIVATING NK CELL RECEPTORS IN CHILDHOOD M7 AND NON-M7 AML
Fuster Soler, Jose Luis (Spain)

P 068 PTPN11 mutations in the pathogenesis of pediatric myeloid neoplasms
Almeida, Daniela (Brazil)

P 069 Follow-up of children with non APL-AML treated with NOPHO: A Brazilian single-center experience
Azevedo, Amilcar (Brazil)

P 070 The role of multi-сolor flow cytometry for disease monitoring in сhildhood acute myeloid leukemia: data from the Republic of Belarus
Borovskaya, Julia (Belarus)

P 071 RAS pathway mutations in pediatric acute promyelocytic leukemia
Brisson, Gisele (Brazil)

P 072 EPHX1, MPO and GSTT1 genetic polymorphisms are associated with susceptibility to childhood acute myeloid leukemia
Brisson, Gisele (Brazil)

P 073 Long-term remission after the cytoreduction in a phenotypically normal trisomy 21 mosaic infant with megakarioblastic leukemia with GATA1 mutation and OTT-MAL expression
Fedorova, Alina (Belarus)

P 074 ACUTE MONOBLASTIC LEUKEMIA: 18-YEARS EXPERIENCE IN ARGENTINA
Guitter, Myriam R. (Argentina)

P 075 Myelodisplastic features and secondary myelodisplasia in patients with FLT3-ITD AML. Clinical cases
Kreminska, Olena (Ukraine)

P 076 Unexpectedly high frequency of translocation t(10;11)(p12;q23) in pediatric acute myeloid leukemia in Poland
Ksiazek, Teofila (Poland)

P 077 Characteristics and outcome of children with acute myeloid leukemia and Down syndrome ineligible for clinical studies
Nakashima, Kentaro (Japan)

P 078 Still no improvement for the treatment of pediatric AML patients with mutated WT1 and FLT3-ITD
Niktoreh, Naghmeh (Germany)

P 079 Next Generation sequencing-based mutational profile of 133 pediatric AML patients from Argentina: Preliminary results
Rubio, Patricia L. (Argentina)

P 080 Pediatric acute myeloid leukemia with FLT3-ITD and WT1 genes mutations - genetic markers with adverse prognosis. Study in two case from the Cracow children's oncology center
Szewczyk, Katarzyna (Poland)

P 081 LncRNA BALR-2-CDK6 axis influences cell differentiation and metabolic status of acute myeloid leukemia
Pigazzi, Martina (Italy)

P 082 Child with Nijmegen breakage syndrome and peripheral T-cell lymphoma: difficulties with diagnosis and treatment
Grutupa, Marika (Latvia)

P 083 Thrombosis frequency in pediatric ALL
Kuhn, Tomas (Czech Republic)

P 084 Haematopoietic stem cell transplantation in children in Republic of Kazakhstan
Aigul, Tulebayeva (Kazakhstan)

P 085 Treatment of pediatric high risk Acute Leukemia patients with TCR alfa/beta cell depleted Haploidentical transplantation in Argentina
Pizzi, Silvia (Argentina)

P 086 METABOLIC SYNDROME IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER THE COMPLETION OF CHEMOTHERAPY
Roganovic, Jelena (Croatia)

P 087 Langerhance Cell Histiocytosis 5 Years After B-cell Acute Lymphoblastic Leukemia
Ashayeri, Neda (Iran)

P 088 BK virus-associated hemorrhagic cystitis in children suffering  malignancies: the report of two cases
Ashayeri, Neda (Iran)

P 089 Delayed Diagnosis of Pediatric Hematol/ Oncology Diseases and  factors that may influence to initiate treatment in a referral center
Lopes, Luiz Fernando (Brazil)

P 090 Mucormycosis in patients with childhood acute leukemia - single center experience
Bačová, Eva (Slovakia)

P 091 Cancer in adolescents (15-18 years): A report from the Slovak Clinical Cancer Registry of Children and Adolescents
Makohusova, Miroslava (Slovakia)

P 092 Changes of immunophenotypic features in JMML during treatment with azacitidine and correlation with clinical response of the patients
Martino Lee, Maria Lucia (Brazil)

P 093 The mutational profile in pediatric patients with myeloproliferative neoplasms
Gaskova, Marina (Russia)

P 094 Exploring the long non-coding RNA landscape in Juvenile Myelomonocytic Leukemia
Hofmans, Mattias (Belgium)

P 095 High Hyperdiploidy in Burkitt Lymphoma of Childhood: Biological and Clinical Correlates
Avgerinou, Georgia (Greece)

P 096 RARE PRESENTATIONS OF NON-HODGKIN’S LYMPHOMAS – A SINGLE CENTER EXPERIENCE
Dana, Eleni (Greece)

P 097 Two cases of secondary T-lymphoblastic lymphoma successfully treated according to BFM-based program
Kovalova, Zhanna (Latvia)

P 098 THE PREDICTIVE VALUE OF 18F-FDG-PET/CT FOR EARLY RESPONSE EVALUATION IN PEDIATRIC NON-HODGKIN LYMPHOMA PATIENTS
Achituv, Sivan (Israel)

P 099 Long-term B-cell reconstitution in pediatric patients with mature B-cell lymphoma after immunochemotherapy with rituximab: Interim results of the Recon-B 17 study
Zhogov, Vladimir (Russia)

P 100 BURKITT LYMHOMA IN A CHILD WITH CRYPTOGENEIC CIRRHOSIS: DIFFICULTIES DURING TREATMENT
Tugcu, Deniz (Turkey)

P 101 Health- related quality of life of children with acute lymphoblastic leukemia in maintenance and after treatment
Aylan Gelen, Sema (Turkey)

P 102 Resistant massive bilateral chyleous effusion on the 43th month of dasatinib treatment in chronic phase chronic myeloid leukemia
Aylan Gelen, Sema (Turkey)

P 103 SPECIFIC TARGETING OF ACUTE MYELOID LEUKEMIA BY THE USE OF NON-VIRALLY ENGINEERED CIK (CYTOKINE-INDUCED KILLER) CELLS EXPRESSING THE ANTI-CD33 CHIMERIC ANTIGEN RECEPTOR (CAR)
Biondi, Andrea (Italy)

P 104 Tylophorine inhibits proliferation and induces cell death in PTEN-deficient T-cell acute lymphoblastic leukemia
Crazzolara, Roman (Austria)

P 105 Brentuximab vedotin (BV) in therapy of relapsed/refractory lymphomas in children before auto-SCT
Kavardakova, Nataliia (Ukraine)

P 106 First experience of check-point inhibitors in the treatment of refractory lymphoma and leukemia in children and adolescents
Miakova, Natalia (Russia)

P 107 Enhanced preclinical activity of a CD20-IgG3 antibody in Burkitt´s lymphoma
Schewe, Denis (Germany)

P 108 CD45 Surface Expression as a Prognostic Factor in Children with Acute Lymphoblastic Leukemia
Hatzipantelis, Emmanouil (Greece)

P 109 EARLY T-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ETP)
Eugenia, Papakonstantinou (Greece)

P 110 Fast and reliable identification of BCR-ABL-like pediatric acute lymphoblastic leukemia (ALL) patients by real-time PCR
Tsaur, Grigory (Russia)

P 111 An analysis of the use of routine serology in reducing the burden of re-immunisation in children who have undergone chemotherapy for childhood Acute Lymphoblastic Leukaemia
Cross, Siobhan (New Zealand)

P 112 Clinical courses and managements of pediatric patients with acute leukemia and hyperleukocytosis: A single-center experience
Ishimaru, Sae (Japan)

P 113 THE USE OF SALSA MLPA P335 KIT IN A NOVEL PROPOSED GENOMIC RISK STRATIFICATION IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA;  RESULTS FROM A GREEK PEDIATRIC COHORT
Polychronopoulou, Sophia (Greece)

P 114 ALL RELAPSES IN CHILDREN TREATED ACCORDING TO BFM PROTOCOLS: 18 YEARS OF EXPERIENCE IN A GREEK CENTER
Polychronopoulou, Sophia (Greece)

P 115 Results of therapy according to the pilot protocol ALL-REZ-2014 for children with relapsed acute lymphoblastic leukemia in the Russian Federation
Diakonova, Yulia (Russia)

P 116 Relapsed childhood acute lymphoblastic leukemia in Slovakia: prognostic factors, treatment and outcome
Kolenova, Alexandra (Slovakia)

P 117 Isolated Central Nervous System Relapse of Acute Lymphoblastic Leukemia Treated With Combination of Chemotherapy and Cranial Radiation
Kilinç, Yurdanur (Turkey)

P 118 Treatment of relapsed/refractory CD33+ acute myeloid leukemia with gemtuzumab ozogamicin in childhood: a case report
Kılınç, Yurdanur (Turkey)

P 119 Acute promyelocytic leukemia (APL) as therapy-related leukemia and second malignant neoplasms following APL: Experience in 2 centers in Argentina
D'Aloi, Karina (Argentina)

P 120 Therapy related Acute Myeloid Leukaemia treated with SCT: a single center study
Li, Chi-kong (China)

 

LOOKING FORWARD TO

MEETING YOU IN HELSINKI IN
12
Months
9
Days
1
Hours
59
Minutes
59
Seconds



Meeting Secretariat: C-IN, 5. kvetna 65, 140 21 Prague 4, CZE | tel.: +420 261 174 301 | fax: +420 261 174 307
Home | Sitemap | info@ibfm2018.org | Copyright © 2017 ibfm2018.org
Powered and created by E-WORKS - web studio | XHTML 1.0 | CSS 2



Meeting Secretariat: C-IN, 5. kvetna 65, 140 21 Prague 4, CZE | tel.: +420 261 174 301 | fax: +420 261 174 307
Home | Sitemap | info@ibfm2018.org | Copyright © 2017 ibfm2018.org
Powered and created by E-WORKS - web studio | XHTML 1.0 | CSS 2